Health Initiative/

Samuel Scarpino, PhD

Managing Director, Pandemic Prevention InstituteHealth Initiative, The Rockefeller Foundation

Samuel V. Scarpino, PhD is the Managing Director of Pathogen Surveillance at the Rockefeller Foundation and a member of their Pandemic Prevention Institute. In addition, Dr. Scarpino is an Affiliate Assistant Professor in the Department of Physics and hold appointments in the Network Science Institute, Khoury College of Computer Sciences, Global Resilience Institute, and Roux Institute at Northeastern University. In this capacity, he directs the Emergent Epidemics Lab and is a Co-founder of Scarpino has 10+ years of experience translating research into decision support and data science/ML tools across diverse sectors from public health and clinical medicine to real estate and energy. From 2017 to 2020, he was Chief Strategy Officer and head of data science at Dharma Platform–a social impact–technology startup. Scarpino has nearly 100 publications in academic journals and books. His expert commentaries on science and technology have appeared in publications such as: Nature, Science, PNAS, and Nature Physics. His research has been covered by the New York Times, Wired, the Boston Globe, NPR, VICE News, National Geographic, and numerous other venues. For his contributions to complex systems science, he was made a Fellow of the ISI Foundation in 2017, an External Faculty member of the Santa Fe Institute in 2020, and an External Faculty member of the Vermont Complex Systems Center in 2021. Scarpino earned a PhD from The University of Texas at Austin in 2013 and was a Santa Fe Institute Omidyar Fellow from 2013 – 2016.

Authored Content

  • Jun 06 2022
    Blueprint The Challenge of Measuring Vaccine Effectiveness In mid-November 2020, as Covid-19 cases were rising and two thousand people were dying every day in the U.S., Americans needed hope. They got it. Hope arrived in a syringe. Effective vaccines were developed in record time, with the promise of ending the current pandemic. The scientific discoveries behind that quick vaccine development are also […] Dave Luo, Jacqueline Houtman, Lindsey Shultz, Samuel Scarpino
  • Mar 25 2022
    Blueprint Variants, Sublineages, and Recombinants: The Constantly Changing Genome of SARS-CoV-2 During the course of the Covid-19 pandemic, numerous variants of SARS-CoV-2 have emerged. Some have died out, and some have surged globally. They are all SARS-CoV-2, but they differ in important ways. Think of them as the boughs of the SARS-CoV-2 family tree, each of which has branched off into many smaller limbs. The smaller […] Dave Luo, Dr. Rick Bright, Jacqueline Houtman, Jessica Malaty Rivera, Jonathan Gilmour, Lindsey Shultz, Samuel Scarpino
Back to Top